Biomarker Discovery in Immunotherapy-treated Melanoma Patients with Imaging Mass Cytometry

PURPOSE: Imaging Mass Cytometry (IMC) is among the first tools with the capacity for multiplex analysis of over 40 targets, which provides a novel approach to biomarker discovery. Here we used IMC to characterize the tumor microenvironment (TME) of patients with metastatic melanoma who received immu...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Cancer Res
Asıl Yazarlar: Martinez-Morilla, Sandra, Villarroel-Espindola, Franz, Wong, Pok Fai, Toki, Maria I., Aung, Thazin Nwe, Pelekanou, Vasiliki, Bourke-Martin, Brian, Schalper, Kurt A, Kluger, Harriet M., Rimm, David L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8026677/
https://ncbi.nlm.nih.gov/pubmed/33504554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-20-3340
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller